Abstract
Remdesivir is an intravenous inhibitor of the viral RNA-dependent RNA polymerase with in vitro and in vivo activity against Middle East respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and SARS-CoV-2.[1][1]–[3][2] In Canada, it is authorized and
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
